Financials

News Ideas Technicals

ESLA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Estrella Immunopharma, Inc.

Total assets of ESLA for Q3 24 is 8.63 M USD, 8.61% less than the previous Q2 24. And total liabilities decreased by 65.27% in Q3 24 to 138.49 k USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—